GMEDGlobus Medical, Inc.Healthcare · Medical - Devicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $75.26 · now $75.26 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, GMED has typically landed between $64.22 and $86.41 — a range of −14.7% to +14.8% from the issuance price $75.26.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

3,528 overlapping 1 month windows · 2012-08-032026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($75.26) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where GMED has typically landed a month from the 2026-09-16 close of $75.26 — the range is history, not a prediction.

$64.22worst · -14.7%$86.41best · +14.8%
  • now $75.26 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $75.29 (+0.0%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $70.77$79.82
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $64.22$86.41
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 3,528 windows spanning 2012-08-03 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-13−37.9%−37.9%+0.3%
2020-02-12−33.1%−33.1%+1.9%
2020-02-18−32.2%−38.1%+0.0%
3 best
2025-10-10+52.7%+0.0%+52.7%
2025-11-05+48.1%+0.0%+48.2%
2025-10-29+48.1%−1.8%+48.3%

3,528 overlapping windows · 2012-08-032026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~15 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
57%
+3.0%
n=14
Feb
71%
−0.3%
n=14
Mar
50%
+0.3%
n=14
Apr
57%
+0.6%
n=14
May
50%
+1.0%
n=14
Jun
43%
+0.4%
n=14
Jul
57%
+0.6%
n=14
Aug
64%
+1.1%
n=14
Sep
33%
−2.3%
n=15
Oct
71%
+3.3%
n=14
Nov
64%
+6.5%
n=14
Dec
71%
+3.0%
n=14

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$97$552026-09-15: 1 insider sale, $2.2M — TOBIN JAMES R2026-08-18: 1 insider sale, $2.2M — ZARRILLI STEPHEN T2026-06-05: 1 insider sale, $2.0M — Davidar David D2026-02-25: 1 insider sale, $1.9M — Huller Kelly2026-02-12: 1 insider sale, $877K — Huller Kelly2026-01-08: 2 insider sales, $566K — Kline Kyle, Norwalk Leslie V2025-12-12: 1 insider sale, $355K — Norwalk Leslie V2025-12-01: 1 insider sale, $1.7M — Kline Kyle2025-11-25: 1 insider sale, $675K — Huller Kelly2025-11-12: 1 insider sale, $2.2M — Davidar David D2025-11-11: 1 insider sale, $2.1M — ZARRILLI STEPHEN T2025-11-10: 1 insider sale, $170K — RHOADS ANN D2025-11-07: 1 insider sale, $648K — RHOADS ANN D2025-09-15: 1 insider sale, $585K — RHOADS ANN D2025-09: 1 open-market sale, $585K2025-11: 5 open-market sales, $5.8M2025-12: 2 open-market sales, $2.0M2026-01: 2 open-market sales, $566K2026-02: 2 open-market sales, $2.8M2026-06: 1 open-market sale, $2.0M2026-08: 1 open-market sale, $2.2M2026-09: 1 open-market sale, $2.2M↑ buys↓ salesdirector TOBIN JAMES R — Sale on 2026-09-15, filed 1 day after the tradedirector ZARRILLI STEPHEN T — Sale on 2026-08-18, filed 1 day after the tradedirector Davidar David D — Sale on 2026-06-05, filed 4 days after the tradeofficer Huller Kelly — Sale on 2026-02-25, filed 2 days after the tradeofficer Huller Kelly — Sale on 2026-02-12, filed 5 days after the tradeofficer Kline Kyle — Sale on 2026-01-08, filed 4 days after the tradedirector Norwalk Leslie V — Sale on 2026-01-08, filed 4 days after the tradedirector Norwalk Leslie V — Sale on 2025-12-12, filed 4 days after the tradeofficer Kline Kyle — Sale on 2025-12-01, filed 2 days after the tradeofficer Huller Kelly — Sale on 2025-11-25, filed 3 days after the tradedirector Davidar David D — Sale on 2025-11-12, filed 1 day after the tradedirector ZARRILLI STEPHEN T — Sale on 2025-11-11, filed 2 days after the tradedirector RHOADS ANN D — Sale on 2025-11-10, filed same daydirector RHOADS ANN D — Sale on 2025-11-07, filed 3 days after the tradedirector RHOADS ANN D — Sale on 2025-09-15, filed 1 day after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-09-15TOBIN JAMES RdirectorSale30,000 @ $74.58$2.2M−100.0% of holdingnot yet — horizon still opennot yet — horizon still open0Form 4 · filed 1 day after the trade
2026-08-18ZARRILLI STEPHEN TdirectorSale25,000 @ $87.04$2.2M−100.0% of holdingnot yet — horizon still opennot yet — horizon still open0Form 4 · filed 1 day after the trade
2026-06-05Davidar David DdirectorSale25,000 @ $80.76$2.0M−4.7% of holding−6.1%not yet — horizon still open510,175Form 4 · filed 4 days after the trade
2026-02-25Huller KellyofficerSale20,000 @ $94.50$1.9M−100.0% of holding−3.4%−24.7%0Form 4 · filed 2 days after the trade
2026-02-12Huller KellyofficerSale10,000 @ $87.67$877K−100.0% of holding+0.1%−16.1%0Form 4 · filed 5 days after the trade
2026-01-08Kline KyleofficerSale3,594 @ $101.10$363K−100.0% of holding−8.1%−24.9%0Form 4 · filed 4 days after the trade
2026-01-08Norwalk Leslie VdirectorSale2,000 @ $101.10$202K−16.1% of holding−8.1%−24.9%10,419Form 4 · filed 4 days after the trade
2025-12-12Norwalk Leslie VdirectorSale4,000 @ $88.85$355K−24.4% of holding+5.1%−21.3%12,419Form 4 · filed 4 days after the trade
2025-12-01Kline KyleofficerSale18,542 @ $90.00$1.7M−100.0% of holding−3.3%−24.7%0Form 4 · filed 2 days after the trade
2025-11-25Huller KellyofficerSale7,500 @ $90.00$675K−100.0% of holding−5.6%−22.9%0Form 4 · filed 3 days after the trade
2025-11-12Davidar David DdirectorSale25,000 @ $86.00$2.2M−4.6% of holding+2.6%−18.3%516,275Form 4 · filed 1 day after the trade
2025-11-11ZARRILLI STEPHEN TdirectorSale25,000 @ $84.29$2.1M−100.0% of holding+3.7%−19.3%0Form 4 · filed 2 days after the trade
2025-11-10RHOADS ANN DdirectorSale2,000 @ $85.00$170K−11.5% of holding+0.8%−22.0%15,384Form 4 · filed same day
2025-11-07RHOADS ANN DdirectorSale8,000 @ $81.00$648K−31.5% of holding+3.6%−19.9%17,384Form 4 · filed 3 days after the trade
2025-09-15RHOADS ANN DdirectorSale10,000 @ $58.46$585K−28.3% of holding−0.7%+49.3%25,384Form 4 · filed 1 day after the trade
2025-02-28RHOADS ANN DdirectorSale7,500 @ $78.68$590K−17.5% of holding−3.3%−32.9%35,384Form 4 · filed 4 days after the trade
2025-01-10Pfeil Keith WdirectorSale12,501 @ $88.17$1.1M−88.2% of holding−7.5%−43.6%1,666Form 4 · filed 4 days after the trade
2025-01-10Pfeil Keith WdirectorSale1,666 @ $89.17$149K−100.0% of holding−7.5%−43.6%0Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

64 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-15TOBIN JAMES RdirectorOption exercise15,00030,000Form 4
2026-09-15TOBIN JAMES RdirectorOption exercise15,00015,000Form 4
2026-09-15TOBIN JAMES RdirectorOption exercise15,0000Form 4
2026-08-18ZARRILLI STEPHEN TdirectorOption exercise25,00025,000Form 4
2026-08-18ZARRILLI STEPHEN TdirectorOption exercise25,0000Form 4
2026-07-27Davidar David DdirectorGift2,500507,675Form 4
2026-06-05Davidar David DdirectorOption exercise25,000535,175Form 4
2026-06-05Davidar David DdirectorOption exercise25,0000Form 4
2026-06-04RHOADS ANN DdirectorOption exercise25,00040,384Form 4
2026-06-04RHOADS ANN DdirectorOption exercise25,0000Form 4
2026-02-25Huller KellyofficerOption exercise20,00020,000Form 4
2026-02-25Huller KellyofficerOption exercise20,00020,000Form 4
2026-02-12Huller KellyofficerOption exercise10,00010,000Form 4
2026-02-12Huller KellyofficerOption exercise10,0000Form 4
2026-01-21RHOADS ANN DdirectorAward / grant15,00015,000Form 4
2026-01-21Huller KellyofficerAward / grant40,00040,000Form 4
2026-01-21Davidar David DdirectorAward / grant15,00015,000Form 4
2026-01-21Wolterman DandirectorAward / grant15,00015,000Form 4
2026-01-21DeFord John AdirectorAward / grant15,00015,000Form 4
2026-01-21ZARRILLI STEPHEN TdirectorAward / grant15,00015,000Form 4
2026-01-21TOBIN JAMES RdirectorAward / grant15,00015,000Form 4
2026-01-21Paul David CdirectorAward / grant100,000100,000Form 4
2026-01-21Pfeil Keith WdirectorAward / grant100,000100,000Form 4
2026-01-21Lemaitre DandirectorAward / grant15,00015,000Form 4
2026-01-21Douglas Robert AndrewdirectorAward / grant15,00015,000Form 4
2026-01-21Kline KyleofficerAward / grant30,00030,000Form 4
2026-01-21Norwalk Leslie VdirectorAward / grant15,00015,000Form 4
2026-01-08Kline KyleofficerOption exercise3,5943,594Form 4
2026-01-08Kline KyleofficerOption exercise3,5943,906Form 4
2025-12-08Paul David CdirectorOption exercise34,37560,417Form 4
2025-12-08Paul David CdirectorOption exercise34,3750Form 4
2025-12-01Kline KyleofficerOption exercise5,00013,646Form 4
2025-12-01Kline KyleofficerOption exercise4,89618,542Form 4
2025-12-01Kline KyleofficerOption exercise5,0008,646Form 4
2025-12-01Kline KyleofficerOption exercise3,6463,646Form 4
2025-12-01Kline KyleofficerOption exercise5,0000Form 4
2025-12-01Kline KyleofficerOption exercise3,6461,354Form 4
2025-12-01Kline KyleofficerOption exercise5,00010,000Form 4
2025-11-25Huller KellyofficerOption exercise7,5007,500Form 4
2025-11-25Huller KellyofficerOption exercise7,5000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.